Thyroid

In this video exclusive, Putting It Into Practice columnist Jonathan D. Leffert, MD, talks with Natalie Cusano, MD, about hyperparathyroidism and osteoporosis.

Endocrinologists must do more to reduce overdiagnosis of common, low-risk thyroid cancers and tailor any treatments to reduce potential harm, according to a speaker at the American Association of Clinical Endocrinology virtual meeting.

Likelihood of testing positive for thyroglobulin antibodies is increased for people with higher LDL cholesterol and decreased for those with higher HDL cholesterol levels, particularly among women, according to study data.

The abundance and diversity of intestinal microbiota are reduced in adults with Graves’ disease, and Lactobacillus may be one of the pivotal factors activating autoimmune response, according to data published in Thyroid.

Most adults with thyroid eye disease receiving an infusion of teprotumumab every 3 weeks for a 24-week period had a reduction of at least 2 mm in proptosis, with a long-term response observed in 67% of participants, according to study data.

Providers should consider clinical context, including comorbidities, when diagnosing and managing thyroid cancer in older adults, according to a study published in Thyroid.

Most physicians treating patients with thyroid cancer said they would suppress thyroid-stimulating hormone in those with low- and intermediate-risk thyroid cancer, according to a study published in Thyroid.

A high human chorionic gonadotropin level in early pregnancy is associated with lower risk for developing gestational diabetes, with maternal free thyroxine level acting as an important mediator, according to data published in Thyroid.

An updated guideline for best practices in managing anaplastic thyroid cancer stresses the need for patient-centered care, considering disease stage and quality of life before attempting aggressive disease management.

Surveillance after treatment for low-risk thyroid cancer is a balancing act that must consider treatment modality and patient concerns about recurrence, but several considerations can help stratify who should receive follow-up screenings.